What is the ticker symbol for Acelyrin?

Acelyrin trades under the ticker SLRN on NASDAQ.

What sector does Acelyrin operate in?

Acelyrin is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SLRN in a portfolio?

PortView shows SLRN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Acelyrin (SLRN) Stock Analysis

NASDAQHealthcareBiotechnology

$2.27+0.00%

1-year price historyRange $1.89 – $7.06

52-week range$2.27

$1.85$7.25

What Acelyrin does

Acelyrin, Inc. is a biopharmaceutical company focused on discovering, obtaining, and rapidly advancing the development and commercialization of innovative medical therapies. The firm's most advanced experimental drug is izokibep, a potent small protein therapeutic specifically designed to block IL-17A. This compound is currently undergoing Phase 3 clinical evaluations for its use in treating Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis. Additionally, izokibep is being assessed in Phase 2 clinical trials for Axial Spondyloarthritis. Beyond izokibep, Acelyrin is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets the insulin-like growth factor 1 receptor. Lonigutamab is in Phase 1 clinical studies for individuals with thyroid eye disease. Furthermore, the company has SLRN-517, a fully human IgG1 monoclonal antibody aimed at c-KIT, which is in the preclinical stage of development for the treatment of chronic urticaria. Founded in 2020, Acelyrin's corporate headquarters are located in Agoura Hills, California.

Key metrics

Market cap

$229.17M

P/E (TTM)

-0.84

EPS (TTM)

$-2.69

Beta

1.09

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.40

200-day avg

$3.55

52-week high

$7.25

52-week low

$1.85

CEO

Mina Kim

ETFs linked to SLRN

Broad-market and Healthcare sector ETFs an investor holding Acelyrin is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SLRN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SLRN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Acelyrin?: Acelyrin trades under the ticker SLRN on NASDAQ.
Which exchange is SLRN listed on?: SLRN is listed on NASDAQ.
What sector does Acelyrin operate in?: Acelyrin is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SLRN in a portfolio?: PortView shows SLRN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.